Hepatic Failure Clinical Trial
Official title:
A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [Pf-01913539] In Subjects With Hepatic Impairment And Normal Hepatic Function
1. To compare the pharmacokinetics of Dimebon in subjects with mild and moderate hepatic
impairment to subjects with normal hepatic function.
2. To assess the safety and tolerability of Dimebon in subjects with hepatic impairment
and subjects with normal hepatic function.
3. To explore the pharmacokinetics of Dimebon in subjects with severely-impaired hepatic
function.
n/a
Allocation: Non-Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT02516319 -
Liver Function Assessment - Feasibility and Dosing Study
|
N/A | |
| Completed |
NCT04587622 -
Pharmacokinetic Study of Icenticaftor in Participants With Hepatic Impairment
|
Phase 1 | |
| Recruiting |
NCT05604469 -
The Role of Skin Microbiota in Hepatic or Renal Pruritus
|
||
| Completed |
NCT03576859 -
Pyrophosphate Homeostasis and Hepatic Expression of ABCC6.Pyro-TH
|
N/A | |
| Withdrawn |
NCT02552901 -
Cardiox Liver Function Test Pivotal Trial
|
Phase 3 | |
| Completed |
NCT03515980 -
An Investigational Study of Experimental Medication BMS-986231 Given in Participants With Different Levels of Liver Function
|
Phase 1 | |
| Not yet recruiting |
NCT03560414 -
The Plasma Diafiltration Therapy of Hepatic Failure
|
N/A | |
| Recruiting |
NCT06179368 -
Throid Dysfunction in Liver Failure and Its Eddects Upon Outcome
|
||
| Completed |
NCT01846455 -
Single Dose Pharmacokinetics of Suboxone Study in Hepatic Impaired Subjects
|
Phase 4 |